In order to determine whether BNIP3L functions as a tumour suppressor gene in breast and/or ovarian cancer, we have analysed its expression in ovarian and breast cancer cell lines and screened all exons for mutations in a panel of primary ovarian and breast cancers. This evidence concerns the gene BNIP3L and breast carcinoma.